NSC243928 Treatment Induces Anti-Tumor Immune Response in Mouse Mammary Tumor Models
Benson Chellakkan Selvanesan(The University of Texas MD Anderson Cancer Center), Geeta Upadhyay(University of Chicago)
Cited by 6
Related Papers
Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice
|Journal for ImmunoTherapy of Cancer|2020|28
Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice
|bioRxiv (Cold Spring Harbor Laboratory)|2020|4